- Home
- IVVD vs AKA Comparison
IVVD vs AKA Comparison
Compare IVVD & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- AKA
- Stock Information
- Founded
- IVVD 2020
- AKA 2018
- Country
- IVVD United States
- AKA United States
- Employees
- IVVD N/A
- AKA N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- AKA Catalog/Specialty Distribution
- Sector
- IVVD Health Care
- AKA Consumer Discretionary
- Exchange
- IVVD Nasdaq
- AKA Nasdaq
- Market Cap
- IVVD 123.8M
- AKA 126.7M
- IPO Year
- IVVD 2021
- AKA 2021
- Fundamental
- Price
- IVVD $0.65
- AKA $7.99
- Analyst Decision
- IVVD Strong Buy
- AKA Buy
- Analyst Count
- IVVD 3
- AKA 4
- Target Price
- IVVD $7.52
- AKA $22.25
- AVG Volume (30 Days)
- IVVD 1.8M
- AKA 6.8K
- Earning Date
- IVVD 05-15-2025
- AKA 05-13-2025
- Dividend Yield
- IVVD N/A
- AKA N/A
- EPS Growth
- IVVD N/A
- AKA N/A
- EPS
- IVVD N/A
- AKA N/A
- Revenue
- IVVD $25,384,000.00
- AKA $574,697,000.00
- Revenue This Year
- IVVD $606.63
- AKA $6.56
- Revenue Next Year
- IVVD $83.30
- AKA $4.25
- P/E Ratio
- IVVD N/A
- AKA N/A
- Revenue Growth
- IVVD N/A
- AKA 5.21
- 52 Week Low
- IVVD $0.36
- AKA $7.08
- 52 Week High
- IVVD $2.74
- AKA $33.73
- Technical
- Relative Strength Index (RSI)
- IVVD 52.71
- AKA 38.31
- Support Level
- IVVD $0.52
- AKA $7.13
- Resistance Level
- IVVD $0.80
- AKA $7.65
- Average True Range (ATR)
- IVVD 0.08
- AKA 0.61
- MACD
- IVVD 0.01
- AKA 0.19
- Stochastic Oscillator
- IVVD 50.70
- AKA 51.83
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.